Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
The Magnificence of Extraordinariness: Presenting Valuable Adornments and Gemstones - 2IDF uncovers 7 km.-long Gaza terror tunnel where Hamas held Hadar Goldin
- 3Make your choice for the music application with the most amicable connection point!
- 4When darkness shines: How dark stars could illuminate the early universe
- 5Computerized Strengthening d: A Survey of \Upgrading Efficiency\ Programming Application
- Monetary Strengthening: Assuming Command over Your Cash
- The best overlooked performances of 2025
- Language Learning Stages: Which One Gets Your Vote?
- Bolsonaro briefly leaves Brazilian prison for medical tests after a fall from his bed
- Tragedy in Minnesota, vaccine news, Snoop's game call: Week in review
- UK, Canada, Germany, others condemn Israel's West Bank settlement plan
- How one man's concern saved his brothers from heart disease
- Astronauts head home early after medical issue
- Bullets in Luigi Mangione’s bag convinced police that he was UnitedHealthcare CEO killing suspect
